Lockdowns and arthritis meds: did patients stop their treatment?
NCT ID NCT04355923
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at how the COVID-19 lockdown affected people with spondyloarthritis, a type of arthritis. Researchers surveyed 1,000 patients to see if they stopped their usual treatments during confinement and what psychological factors might have played a role. The goal was to understand treatment habits during a stressful period, not to test a new drug.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SPONDYLOARTHRITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU de Nice
Nice, 06300, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a gut microbiome transplant ease axial spondyloarthritis?
- Can group learning make biotherapy safer for arthritis patients?
- Gentle tai chi may get spondyloarthritis patients moving
- Immune clues in the blood may foretell heart trouble
- Can a 4-Minute chat rival a Dietitian's hour for heart health?
- Could low vitamin c explain lingering pain in rheumatism and lupus?